Want to see HK:0722 full AI Analyst Report?
UMP Healthcare Holdings Limited (0722) AI Stock Analysis
UMP Healthcare Holdings Limited
(HKEX:0722)
The score is driven primarily by sharply weakened operating performance and a negative earnings-based valuation signal. Low leverage and positive cash generation provide support, but bearish technical trends and substantial revenue and profit deterioration keep the overall score low.
UMP Healthcare Holdings Limited (0722) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 296.00M
- Dividend Yield
- 9.04%
- Average Volume (3M)
- 77.66K
- Price to Earnings (P/E)
- -3.8
- Beta (1Y)
- 0.23
- Revenue Growth
- -1.37%
- EPS Growth
- -334.69%
- Country
- Hong Kong
- Employees
- 494
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
UMP Healthcare Holdings Limited Business Overview & Revenue Model
Company Description
UMP Healthcare Holdings Limited, an investment firm, delivers a broad spectrum of medical and wellness provisions across Hong Kong, Macau, and mainland China. The company's operations are divided into two main divisions: Corporate Healthcare Solution...
UMP Healthcare Holdings Limited Financial Statement Overview
Summary
Severe revenue and profitability deterioration, including a 91.5% revenue decline and a HK$74.6 million net loss, materially outweighs the strengths of the low-leverage balance sheet and positive cash flow.
Income Statement
18Very NegativeBalance Sheet
78PositiveCash Flow
55Neutral| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 717.12M | 716.97M | 727.36M | 748.49M | 727.75M | 666.20M |
| Gross Profit | 424.51M | 375.02M | 490.61M | 692.25M | 502.69M | 463.95M |
| EBITDA | 28.11M | 26.97M | 143.30M | 161.98M | 178.21M | 168.03M |
| Net Income | -74.64M | -74.64M | 31.44M | 40.64M | 60.45M | 72.17M |
Balance Sheet | ||||||
| Total Assets | 990.71M | 990.71M | 1.10B | 1.11B | 1.12B | 1.04B |
| Cash, Cash Equivalents and Short-Term Investments | 367.89M | 367.89M | 341.70M | 307.49M | 318.58M | 291.65M |
| Total Debt | 143.94M | 143.94M | 161.55M | 172.57M | 172.22M | 148.34M |
| Total Liabilities | 338.39M | 338.39M | 343.53M | 362.14M | 351.54M | 300.30M |
| Stockholders Equity | 640.21M | 640.21M | 742.63M | 725.94M | 740.55M | 698.65M |
Cash Flow | ||||||
| Free Cash Flow | 104.73M | 104.73M | 133.76M | 91.54M | 80.71M | 26.40M |
| Operating Cash Flow | 127.02M | 127.02M | 145.40M | 148.78M | 190.04M | 110.91M |
| Investing Cash Flow | -80.85M | -80.85M | 4.13M | -68.49M | -134.09M | -77.12M |
| Financing Cash Flow | -86.01M | -86.01M | -100.00M | -117.13M | -53.67M | -90.98M |
UMP Healthcare Holdings Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0722, the sentiment is Neutral. The current price of 0.38 is below the 20-day moving average (MA) of 0.39, below the 50-day MA of 0.41, and below the 200-day MA of 0.45, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 42.58 is Neutral, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:0722.
UMP Healthcare Holdings Limited Peers Comparison
Overall Rating
HK:607866Neutral
HK:386954Neutral
HK:245343Neutral- HK:072242Neutral
HK:388641Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:6078 | 66Neutral | HKD 5.84B | 27.75 | 2.55% | ― | 1.59% | -58.55% |
| HK:3869 | 54Neutral | HKD 467.79M | -143.32 | -0.41% | ― | 3.16% | -101.02% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:2453 | 43Neutral | HKD 489.79M | -2.68 | -8.65% | ― | 47.93% | 65.94% |
| HK:0722 | 42Neutral | HKD 292.35M | -3.79 | -10.76% | 9.04% | -1.37% | -334.69% |
| HK:3886 | 41Neutral | HKD 1.10B | 78.09 | 0.48% | 1.10% | -3.26% | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:0722 | UMP Healthcare Holdings Limited | 0.38 | -0.07 | -15.35% | |
| HK:2279 | Yonghe Medical Group Co., Ltd. | 2.19 | 0.32 | 17.10% | |
| HK:3869 | Hospital Corporation of China Ltd | 3.28 | -2.71 | -45.24% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.15 | -0.12 | -43.01% | |
| HK:6078 | Hygeia Healthcare Holdings Co., Ltd. | 9.80 | -3.34 | -25.38% | |
| HK:2453 | Concord Healthcare Group Co., Ltd. Class H | 0.59 | -1.76 | -74.79% |
UMP Healthcare Holdings Limited Corporate Events
UMP Healthcare Sets AGM to Approve Dividend, Board Slate and Share Buyback Mandate
UMP Healthcare Holdings Limited has convened its annual general meeting for 20 November 2026 in Hong Kong, where shareholders will review and adopt the audited consolidated financial statements and directors’ and auditor’s reports for the...
UMP Healthcare Swings to Loss as Impairments Hit Earnings and Dividend
UMP Healthcare Holdings Limited reported a slight 1.4% year-on-year decline in revenue to HK$716.97 million for the year ended 30 June 2026, while total assets fell 9.6% to HK$990.71 million and shareholders’ funds decreased 13.8% to HK$640.21...
UMP Healthcare Declares Final Dividend for FY2026
UMP Healthcare Holdings Limited has declared a final ordinary cash dividend of HKD 0.014 per share for the financial year ended 30 June 2026, underscoring its intention to return value to shareholders. The dividend is subject to shareholder approval...
UMP Healthcare Sets Board Meeting to Approve 2026 Annual Results and Consider Dividend
UMP Healthcare Holdings Limited has scheduled a board meeting for 24 September 2026 to review and approve the consolidated annual results for the financial year ended 30 June 2026. The board will also consider recommending a final dividend and addres...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 23, 2026